LWA
ARIA

Lenox Wealth Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Lenox Wealth Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-142
Closed -$1K – 350
2014
Q3 		$1K Hold
142
– – ﹤0.01% 277
2014
Q2 		$1K Hold
142
– – ﹤0.01% 180
2014
Q1 		$1K Hold
142
– – ﹤0.01% 188
2013
Q4 		$1K Hold
142
– – ﹤0.01% 369
2013
Q3 		$3K Hold
142
– – ﹤0.01% 223
2013
Q2 		$2K Buy
+142
New +$2.52K ﹤0.01% 223

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lenox Wealth Advisors's ARIA Position: Q4 2014 in Review

Lenox Wealth Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2014, closing a stake of 142 shares — an estimated $1K sold.

Lenox Wealth Advisors first reported a position in ARIA in Q2 2013 and held it in 6 quarters. The position peaked at $3K in Q3 2013. 179 funds tracked by Wall St. Rank hold ARIA as of Q4 2014.

  • Lenox Wealth Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Lenox Wealth Advisors sold 142 Ariad Pharmaceuticals Inc shares in Q4 2014, an estimated $1K.
  • Lenox Wealth Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 6 quarters.
  • Lenox Wealth Advisors's Ariad Pharmaceuticals Inc position peaked at $3K in Q3 2013.
  • 179 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2014.

Based on Lenox Wealth Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.